Alpha Tau Medical provides highly potent and conformal Alpha Emitters Radiotherapy (Alpha DaRT) for the treatment of solid cancer tumors. AlphaDart is an alpha-ray brachyteatment that releases energized alpha ray only to the tumor area, increasing the effectiveness while reducing the risk of radiation exposure. Alpha Tau was listed on the NASDAQ as a part of a special-purpose-acquisition-company on March 2022. (NASDAQ: DRTS)